C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/20 (2006.01) A61K 31/4965 (2006.01) A61K 31/53 (2006.01) C07D 241/18 (2006.01) C07D 253/07 (2006.01)
Patent
CA 2265672
Corticotropin releasing factor (CRF) antagonists of Formula (I), and their use in treating psychiatric disorders and neurological diseases including major depression, anxiety-related disorders, post-traumatic stress disorders, supranuclear palsy and eating disorders.
L'invention concerne des antagonistes du facteur de libération de corticotropine (CRF) de la formule (I) ainsi que leur utilisation dans le traitement de troubles psychiatriques et de maladies neurologiques notamment de la dépression majeure, de troubles relatifs à l'anxiété, d'états de stress post-traumatique, de la paralysie supranucléaire et de troubles de l'alimentation.
Arnold Charles R. III
Arvanitis Argyrios Georgios
Frietze William E.
Olson Richard E.
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
Du Pont Pharmaceuticals Company
LandOfFree
Pyrazinones and triazinones and their derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazinones and triazinones and their derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazinones and triazinones and their derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1884058